ESC 365 - From ischaemia to arrhythmia. Predicting atrial fibrillation after an acute coronary syndrome. Insights from the BACS & BAMI study

ESC2025 Premium Access

From ischaemia to arrhythmia. Predicting atrial fibrillation after an acute coronary syndrome. Insights from the BACS & BAMI study

Session: Atrial fibrillation management: from asymptomatic patients to cardiac survivors

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Larre Guerra (Madrid, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jaime Francisco Larre Guerra

Foundation Jimenez Diaz, Madrid (Spain)

4 presentations

0 follower

7 more presentations in this session

Association between the presence or absence of symptoms and clinical outcomes in non-elderly patients with sustained atrial fibrillation without a history of heart failure: the Fushimi AF Registry

Speaker: Doctor Y. Ide (Kyoto, JP)

Ethnic disparities and socioeconomic factors in cardiac arrest risk among atrial fibrillation patients

Speaker: Doctor A. Brgdar (Washington, US)

Registry of atrial fibrillation in Latin America: Primary results of the LACROSS Study

Speaker: Doctor P. Barros E Silva (Sao Paulo, BR)

An aggressive electrophysiologist-guided rhythm control strategy significantly reduces hospital admissions in patients presenting with atrial fibrillation in the emergency department. Data from the HE

Speaker: Doctor N. Argyriou (Athens, GR)

Effect of telemedicine-based integrated management of atrial fibrillation in village vlinics on recurrent nonfatal events: a secondary analysis from the miracle-af trial

Speaker: Doctor W. Liu (Nanjing, CN)

Access the full session

Atrial fibrillation management: from asymptomatic patients to cardiac survivors

Speakers: Doctor J. Larre Guerra, Doctor Y. Ide, Doctor A. Brgdar, Doctor P. Barros E Silva, Doctor N. Argyriou...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources